References

Periarterial or perivenous invasion is an independent indicator of lymph node metastasis in invasive breast carcinoma of no special type

10.1016/j.prp.2024.155407 · 2024 · External reference

EVG-based periarterial/perivenous invasion (periA/V) as a high-sensitivity surrogate marker for lymph node metastasis in pT1 invasive breast carcinoma of no special type

10.3390/diseases14050177 · 2026 · External reference

Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study

2021 · External reference

Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer

10.1093/jnci/djp090 · 2009 · External reference

The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer

10.4048/jbc.2011.14.3.198 · 2011 · External reference

The prognostic significance of lymphovascular invasion in invasive breast carcinoma

10.1002/cncr.26711 · 2012 · External reference

Prognostic significance of lymphatic vessel invasion diagnosed by D2-40 in Chinese invasive breast cancers

10.1097/md.0000000000008490 · 2017 · External reference

Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes

10.3389/fonc.2023.1269971 · 2023 · External reference

Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer

10.1016/s0002-9610(02)00950-9 · 2002 · External reference

Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer

10.1186/s12885-020-07101-y · 2020 · External reference

Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers

10.1097/00000658-199911000-00012 · 1999 · External reference

Mechanisms of lymphatic metastasis

10.1172/jci71606 · 2014 · External reference

Lymphatic vessels in cancer

10.1152/physrev.00039.2021 · 2022 · External reference

Insights into the mechanisms of lymph node metastasis

10.1002/cncr.11464 · 2003 · External reference

Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences

10.1097/pas.0b013e31806841f6 · 2007 · External reference

A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors

10.1097/01.lab.0000028824.03032.ab · 2002 · External reference

D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion

2011 · External reference

Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms

10.1309/m7d5ktvyye51xyqa · 2008 · External reference

Podoplanin expression in basal and myoepithelial cells: utility and potential pitfalls

10.1097/pai.0b013e3181c65141 · 2010 · External reference

Value of podoplanin as an immunohistochemical marker in tumor diagnosis: a review and update

10.1097/pai.0b013e31828a83c5 · 2014 · External reference

Unresolved reference

2025 · External reference

Breast cancer prognostic classification in the molecular era: the role of histological grade

10.1186/bcr2607 · 2010 · External reference

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

10.1111/j.1365-2559.1991.tb00229.x · 1991 · External reference

Immunohistochemical assessment of hormone receptor status using a new scoring system (J-Score) in breast cancer

10.2325/jbcs.978 · 2007 · External reference

Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update

10.5858/arpa.2018-0902-sa · 2018 · External reference

Prognostic significance of histological therapeutic effect in preoperative chemotherapy for breast cancer

10.1111/pin.12365 · 2016 · External reference

Stratifying the outcome after neoadjuvant treatment using pathological response classification by the Japanese Breast Cancer Society

10.1007/s12282-015-0640-9 · 2016 · External reference

Blood vessel invasion as a predictor of long-term survival for Japanese patients with breast cancer

10.1023/a:1015224703057 · 2002 · External reference

Perineural invasion predicts unfavorable prognosis in patients with invasive breast cancer

10.21873/cdp.10203 · 2023 · External reference

Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer

10.1038/s41598-021-92343-4 · 2021 · External reference

Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma

10.1097/01.pas.0000213316.59176.9b · 2007 · External reference

Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis

10.4048/jbc.2012.15.4.478 · 2012 · External reference

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

10.1038/bmt.2012.244 · 2013 · External reference

Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting

10.5858/133.4.633 · 2009 · External reference

Histopathologic changes following neoadjuvant chemotherapy in various malignancies

10.4103/2229-516x.106353 · 2012 · External reference

A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity

10.1038/sj.bjc.6602844 · 2005 · External reference

Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas

10.1309/2hgnj1gu57jmbjaq · 2008 · External reference

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group

10.1038/modpathol.2015.74 · 2015 · External reference

Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer

10.1038/s41379-020-00714-5 · 2021 · External reference

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy

10.1200/jco.2007.10.6823 · 2007 · External reference

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas

10.1002/cncr.10451 · 2002 · External reference

Pathologic evaluation of breast cancer after neoadjuvant therapy

10.4132/jptm.2016.02.02 · 2016 · External reference